Trial Profile
Anti-TNF monoclonal antibody to treat acute GvHD refractary to the first line therapy with steroids.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Aug 2011
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions
- 02 Aug 2011 New trial record